T1	Chemical	39 78	combined estrogen - progestin therapy (
T2	Chemical	79 87	EPT ) at
T3	Disease	118 135	breast cancer was
T4	Limited_variation	192 202	013 in SLC
T5	Gene_or_protein	202 215	O1B1 ( P = 0.
R1	influences	Arg1:T1	Arg2:T2
R2	treats	Arg1:T1	Arg2:T3
R3	isAssociatedWith	Arg1:T1	Arg2:T4
R4	treats	Arg1:T1	Arg2:T5
R5	isEquivalentTo	Arg1:T2	Arg2:T1
R6	treats	Arg1:T2	Arg2:T3
R7	isAssociatedWith	Arg1:T2	Arg2:T4
R8	isAssociatedWith	Arg1:T2	Arg2:T5
R9	isAssociatedWith	Arg1:T3	Arg2:T1
R10	isAssociatedWith	Arg1:T3	Arg2:T2
R11	isAssociatedWith	Arg1:T3	Arg2:T4
R12	isAssociatedWith	Arg1:T3	Arg2:T5
R13	influences	Arg1:T4	Arg2:T1
R14	isAssociatedWith	Arg1:T4	Arg2:T2
R15	isAssociatedWith	Arg1:T4	Arg2:T3
R16	isAssociatedWith	Arg1:T4	Arg2:T5
R17	influences	Arg1:T5	Arg2:T1
R18	influences	Arg1:T5	Arg2:T2
R19	isAssociatedWith	Arg1:T5	Arg2:T3
R20	isAssociatedWith	Arg1:T5	Arg2:T4
